Are you ready to work on the leading edge of one of the most exciting areas of medical research today? Bioelectronic Medicine is revolutionizing health care by replacing drugs with electrons – using devices to guide nerves to control molecular targets. The possibilities for changing and saving lives are limitless.
“We are on the cusp of treating diseases in new ways that we would not have been imagining five years ago.” –Christopher Czura, PhD, Vice President, Scientific Affairs
Our researchers are learning the language of neural signals and using Bioelectronic Medicine technologies to record, stimulate, and block neural signals.
We’re teaching the body how to heal itself – without side effects.
Beyond even this, we’re exploring how bioelectronics can help us perform early diagnosis to enhance treatment and achieve more successful outcomes.
Revolutionizing how we treat illness and injuries.
The amazing work happening at Northwell Health’s Feinstein Institute for Medical Research is opening up exceptional opportunities in a wide range of areas. We use a team-based approach that combines our expertise in neurophysiology, neuroscience, molecular and cell biology, and bioengineering. We identify physiological triggers, develop new research tools, and medical device technology to ‘tap into’ neural pathways in the body to treat disease and injury. Get to know the positions that make up our team:
Under the direction of Chad Bouton, VP of Advanced Engineering and Director of the Center for Bioelectronic Medicine, we’re developing therapeutic breakthroughs for an incredible variety of injuries and diseases, such as:
- Bleeding/Hemorrhage – We developed the neural tourniquet, a Bioelectronic Medical device that uses electronic nerve stimulation to slow blood loss.
- Paralysis – Limiting damage and providing a pro-regenerative environment to nerve cells after spinal cord injury.
- Cancer – We’re discovering and validating new biomarkers which may serve as targets for Bioelectronic Medicine in various cancers.
- Rheumatoid Arthritis – Electrically stimulating the vagus nerve could turn off the immune system pathways associated with rheumatoid arthritis and other inflammatory diseases.
- Sepsis – We’re developing methods of preventing sepsis and investigating mechanisms underlying the cognitive and physical impairment that occurs in up to 25% of sepsis survivors.
- Colitis – Our researchers have shown that activation of the vagus nerve reduces the symptoms of colitis.
- Crohn’s Disease – We have developed a device to stimulate the vagus nerve in order to activate the body’s natural inflammatory reflex.
- Diabetes – Our research suggests that a small bioelectronics device, implanted on the vagus nerve, may be able to regulate the production of and cellular response to insulin.
- Lupus – We’re studying genetic information to identify individuals who are at risk for developing autoimmune diseases such as Lupus.
- Obesity and Metabolic Syndrome – Proper regulation of vagus nerve-mediated anti-inflammatory signaling might provide an effective treatment of obesity.
The role you can play.
“We are bringing together people from completely different disciplines, into the same area, working together, collaborating and innovating to create new technologies.” — Chad Bouton, VP of Advanced Engineering and Director of the Center for Bioelectronic Medicine
- Molecular Biologists – Target the molecular sources of disease
- Neuroscientists – Identify the neural pathway to manipulate the targeted source
- Neural Electrical Engineers/Computer Scientists – Design the device to manipulate the appropriate pathway in order to treat the disease
Through this unique approach, our employees are developing effective solutions that are less expensive than pharmaceuticals, easier to administer, non-toxic, and more precise. The innovations you produce will minimize health risks and side effects, while offering an extensible R&D platform.
“It’s an extraordinary time to be here and it’s extremely exciting to think about what’s coming next.” –Kevin J. Tracey, MD, President & CEO